Drug Type Small molecule drug |
Synonyms ARN 24922, ARN24922 |
Target |
Mechanism BRCA2 inhibitors(BRCA2 DNA repair associated inhibitors), RAD51 inhibitors(DNA repair protein RAD51 homolog 1 inhibitors) |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Pancreatic Cancer | Preclinical | IT | 02 Jul 2024 |